These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9219019)

  • 21. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial.
    Prakash J; Kotwal A; Prabhu H
    J ECT; 2006 Sep; 22(3):163-8. PubMed ID: 16957530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informed consent in psychiatric research.
    Roth LH; Appelbaum PS; Lidz CW; Benson P; Winslade WJ
    Rutgers Law Rev; 1987; 39(2-3):425-41. PubMed ID: 11659013
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hippocampus: a target for cognition enhancers].
    Arushanian EB; Beĭer EV
    Eksp Klin Farmakol; 2007; 70(4):59-65. PubMed ID: 18078044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-therapeutic medical research involving human subjects.
    Bloom MJ
    Syracuse Law Rev; 1973; 24():1067-1099. PubMed ID: 11664224
    [No Abstract]   [Full Text] [Related]  

  • 26. 'Smart drugs': do they work? Are they ethical? Will they be legal?
    Rose SP
    Nat Rev Neurosci; 2002 Dec; 3(12):975-9. PubMed ID: 12461554
    [No Abstract]   [Full Text] [Related]  

  • 27. [Economics and ethics in public health?].
    Blum R
    Gesundheitswesen; 1999 Jan; 61(1):1-7. PubMed ID: 10081179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selling of organs, the sharing of self.
    Campbell CS
    Second Opin; 1993 Oct; 19(2):69-79. PubMed ID: 10129973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD
    IRB; 1993; 15(5):1-7. PubMed ID: 11659703
    [No Abstract]   [Full Text] [Related]  

  • 31. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 33. Proposal on waiver of informed consent poses major issues for research ethics.
    Maloney DM
    Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
    [No Abstract]   [Full Text] [Related]  

  • 34. Towards responsible use of cognitive-enhancing drugs by the healthy.
    Greely H; Sahakian B; Harris J; Kessler RC; Gazzaniga M; Campbell P; Farah MJ
    Nature; 2008 Dec; 456(7223):702-5. PubMed ID: 19060880
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethical issues in clinical neurological research.
    Shore D; Berg K; Mullican C
    J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy in mental retardation: ethical considerations.
    Fletcher JC
    Ment Retard Dev Disabil Res Rev; 1995; 1():7-13. PubMed ID: 11660293
    [No Abstract]   [Full Text] [Related]  

  • 37. Cognitive enhancers: molecules, mechanisms and minds.
    Frenguelli BG
    Neuropharmacology; 2013 Jan; 64():1. PubMed ID: 22985720
    [No Abstract]   [Full Text] [Related]  

  • 38. What should we do about student use of cognitive enhancers? An analysis of current evidence.
    Ragan CI; Bard I; Singh I;
    Neuropharmacology; 2013 Jan; 64():588-95. PubMed ID: 22732441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, safety, and ethics of cosmetic neurology far from settled.
    Flower K; Li L; Chen CY; Baggott MJ; Galloway GP; Mendelson J
    Clin Pharmacol Ther; 2010 Oct; 88(4):461-3. PubMed ID: 20856245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining reports and policies on cognitive enhancement: approaches, rationale, and recommendations.
    Outram SM; Racine E
    Account Res; 2011; 18(5):323-41. PubMed ID: 21916740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.